Strumento inattivo

Altre lingue Intrexon Corp Nyse

Azioni

US46122T1025

Altre lingue

Precigen, Inc.(NasdaqGS:PGEN) added to Russell 3000 Growth Index	01/07
Precigen, Inc.(NasdaqGS:PGEN) added to Russell Microcap Growth Index	01/07
Precigen, Inc.(NasdaqGS:PGEN) added to Russell 3000E Growth Index	01/07
Precigen, Inc.(NasdaqGS:PGEN) added to Russell 2000 Growth Index	01/07
Precigen, Inc.(NasdaqGS:PGEN) added to Russell 2500 Growth Index	01/07
Precigen, Inc.(NasdaqGS:PGEN) added to Russell Small Cap Comp Growth Index	01/07
Precigen Share Rise After Recurrent Respiratory Papillomatosis Study Shows 51% of Patients Surgery Free	03/06
Precigen, Inc. Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More Than Half of Patients Achieved Complete Response	03/06
Precigen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Earnings Flash (PGEN) PRECIGEN Reports Q1 Revenue $1.1M, vs. Street Est of $1.5M	14/05
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting	25/04
Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy	24/04
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th	28/03
North American Morning Briefing : Tech in Focus on -2-	25/03
Precigen Shares Fall After Downgrade From JPMorgan	22/03
Precigen Reports Full Year 2023 Financial Results and Business Updates	20/03
Precigen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
North American Morning Briefing : Stock Futures -2-	19/03
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis	12/03
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th	05/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Intrexon Corp Nyse

Azioni

US46122T1025

Altre lingue

Filtri